U.S. medical device maker GE HealthCare is reportedly working with advisers to explore options for its China unit including an outright sale, according to a report last week.

The China unit would likely be valued in the billions of dollars but discussions are still at early stages and a more precise number is hard to pinpoint, according to an unnamed source cited by Bloomberg News.

A spokesperson told the outlet on Thursday that it remains committed to supporting patients in China. The country is GE HealthCare's second-largest market, where it has about 7,000 employees, according to its latest annual report.
GE HealthCare has six manufacturing bases in China, where it reported $2.4 billion in revenue in 2024, a 15% drop from a year earlier. It said the anti-corruption campaign directed at the health care sector has contributed to delayed orders and sales last year. In the three months ended in June, the company reported another 3% decline in revenue from the market.

General Electric Co. spun off its medical equipment business in 2023. Shares of GE HealthCare have slid 2% this year, valuing the company at about $35 billion.

The company's chief financial officer said in July that GE will continue to work with its suppliers to move capacity to more tariff-friendly geographies.

Business Affairs Homepage